A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
Clinical trial NCT07604909 · RECRUITING
Trial details
- NCT number
- NCT07604909
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-10
- Primary completion
- 2027-09-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.